Skip to main content
Contact Us
Subscribe
E-Edition
68°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
FDA Conditionally Approves Eli Lilly's Thyroid Cancer Drug For Pediatric Patients With Certain Mutations
May 29, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
LLY
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
May 29, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AMGN
AZN
REMSleep Holdings Shareholder Update
May 29, 2024
Via
NewMediaWire
Exposures
Product Safety
Tickers
RMSL
REMSleep Holdings Shareholder Update
May 29, 2024
Via
TheNewswire.com
Exposures
Product Safety
Tickers
RMSL
Oncotelic Therapeutics (OTC: OTLC) Inks Deal With Mosaic ImmunoEngineering To Sell Clinical-Stage Necroptosis Cancer Therapy Assets
May 29, 2024
Via
News Direct
Exposures
Product Safety
Tickers
IOVA
OTLC
Woman-Owned Small Family Business, Academic Entertainment, Transitions Leadership to the Second Generation
May 24, 2024
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
US Eco-Friendly Direct Thermal Labels for Prepared Food Packaging Announced
May 24, 2024
Via
Press Release Distribution Service
Exposures
Product Safety
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
May 29, 2024
Via
InvestorPlace
Exposures
Product Safety
Tickers
LLY
MRNA
PFE
PRME
Sarepta Downgraded As FDA Decision Date Approaches, Shares Up 50% Over Last Six Months
May 28, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
PFE
RY
SRPT
TSX:RY
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Issues Update on NIH-Funded Program for CNM-Au8® in ALS
May 28, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CLNN
Why Is Agios Pharmaceuticals Stock Trading Higher On Tuesday?
May 28, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AGIO
RPRX
The Sandbox’s Journey from Mobile Gaming to a Leading Web3 Platform with Sebastien Borget
May 28, 2024
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
Compumedics set for record-breaking $46 million FY24 revenue
May 27, 2024
Via
News Direct
Exposures
Product Safety
Tickers
ASX:CMP
BLUE DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action - BLUE
May 27, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
BLUE
BLUE DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action - BLUE
May 27, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
BLUE
Compumedics set for record-breaking $46 million FY24 revenue
May 27, 2024
Via
TheNewswire.com
Exposures
Product Safety
Tickers
ASX:CMP
Ken’s Hardwood Barbecue Hosts Watch Party for Pat Sajak’s Farewell on Wheel of Fortune
May 24, 2024
Via
Get News
Topics
Product Recall
Exposures
COVID-19
Legal
Product Safety
FDA Advisory Panel Supports Approval Of Guardant Health's Blood Test For Colorectal Cancer Screening
May 24, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
GH
Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test
May 24, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
EXAS
GH
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
May 24, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AMGN
BMY
VSTM
BLUE FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action - BLUE
May 23, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
BLUE
BLUE FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action - BLUE
May 23, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
BLUE
CCHR Commends Lawsuit Filed over FDA’s Failure to Act on Citizen Petition to Update Antidepressant Labeling for Persistent Sexual Problems
May 22, 2024
Via
Press Release Distribution Service
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Novo Nordisk's Once-Weekly Insulin Flagged With Risk Of Low Blood Sugar Ahead Of FDA Review
May 22, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
NVO
Pedigree Dog Food Recalls: Was Your Dog Food Pulled From Shelves?
May 22, 2024
Via
InvestorPlace
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
NVDA
WMT
Oil Flattens Despite Heightened Tensions Over Recognition Of Palestinian State
May 22, 2024
Via
Talk Markets
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
BNO
Marlee – Texen Revolutionizes Injection Molding with Cutting-Edge Technology and Superior Quality Services
May 21, 2024
Via
Prodigy
Exposures
Product Safety
Prescient Therapeutics PTX-100 shows promising results in Phase 1b study
May 21, 2024
Via
TheNewswire.com
Exposures
Product Safety
Tickers
ASX:PTX
PSTTF
Prescient Therapeutics PTX-100 shows promising results in Phase 1b study
May 21, 2024
Via
News Direct
Exposures
Product Safety
Tickers
ASX:PTX
PSTTF
Larimar Therapeutics' Friedreich's Ataxia Investigational Drug Differentiated From Biogen's Marketed Drug
May 21, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BIIB
LRMR
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.